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ABSTRACT 
Introduction 
Influenza vaccination through primary care has been recommended for all pre-school children in the 
UK since 2013 as part of a universal immunisation programme. Vaccination is required annually and 
effectiveness varies by season. Factors associated with influenza vaccine receipt and those for other 
childhood vaccines may therefore differ. 
Methods 
We used The Health Improvement Network, a large primary care database, to create a cohort of 
children in England and Wales aged two to four years eligible for vaccination in the 2014/15 season. 
Mixed effects Poisson regression models were used to determine socio-demographic and clinical 
factors associated with influenza vaccine receipt, allowing for practice-level variation.  
Results 
Overall, 38.7% (95% confidence interval (CI) 38.3%, 39.1%) of 57545 children were vaccinated 
against influenza. Children in the poorest deprivation quintile were 19% less likely to receive 
influenza vaccine than those in the wealthiest quintile (adjusted risk ratio (ARR) 0.81, 95% CI 0.77, 
0.86). Children who received a timely first dose of measles-mumps-rubella (MMR) vaccine were 
twice as likely to receive influenza vaccine (ARR 2.00 95% CI 1.87, 2.13). Being four years old, not in a 
clinical risk group, or living with two or more other children were also significantly associated with a 
lower probability of vaccination.  
Discussion 
Children living in areas of higher deprivation and in larger families are less likely to receive influenza 
vaccine. Further research is required into whether interventions such as offering vaccinations in 
other settings could increase uptake in children, particularly in deprived areas.  
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What is already known on this subject? 
 Pre-school children in the UK are offered influenza vaccine annually in primary care as part 
of a universal programme introduced in 2013. 
 A previous study suggested areas with higher deprivation, or higher proportions of non-
white or Muslim populations had lower influenza vaccine uptake in children.  
 There is little data on individual-level demographic, socio-economic or clinical predictors of 
influenza vaccination uptake in pre-school children in the UK.  
What this study adds? 
 Only 39% of children were vaccinated overall; higher deprivation, living with two or more 
other children, age and not receiving a timely first-dose of measles-mumps-rubella (MMR) 
vaccine were significantly associated with not being vaccinated for influenza.  
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INTRODUCTION  
Influenza is a common infection in children, which can lead to hospital admission[1] and, rarely, 
death.[2]. The benefits of vaccination for individual children include a reduced risk of confirmed 
influenza infection.[3,4] These benefits are likely to be higher in children with chronic conditions, 
including neurological or chronic respiratory conditions, who are at increased risk of influenza-
related complications,[5] although there are few clinical trials of influenza vaccine in these groups.  
The UK introduced a universal influenza vaccination programme for children in September 2013. This 
replaced a policy of selective vaccination for children at increased risk of influenza complications due 
to chronic conditions.[6] Under the new programme, which is being progressively rolled out, 
preschool children (aged between two and four years inclusive) are being offered vaccine through 
their general practitioner (family physician). School-age children up to age 16 will be offered 
vaccination at school. The live attenuated vaccine, offered to the vast majority of children under the 
universal programme, has a good safety profile.[7]  
There is a substantial body of research into determinants of routine childhood vaccines in the UK. 
These studies showed an inverse J-shaped relationship between deprivation indicators and the 
likelihood being fully vaccinated in the first year of life.[8,9] Higher parity is associated with lower 
uptake of childhood vaccinations but the association between ethnic group and vaccination uptake 
in children is not consistent across studies.[10-12].  
The universal influenza vaccination programme is different to other childhood immunisation 
programmes. For example, vaccination is required annually and vaccination effectiveness varies 
according to the degree of match between the circulating and vaccination strain of influenza.[3] 
Most importantly, the primary purpose of introducing the universal childhood programme was to 
reduce influenza transmission, and its cost-effectiveness rests on the indirect impact on the 
reduction of severe illness and mortality among the elderly.[13] The modelling study on which the 
recommendation to extend influenza vaccination to all children was based showed that a universal 
policy would be cost-effective even at 30% uptake in children.[14]  
The need for high uptake is therefore less urgent for policy makers, compared to for example the 
need to ensure high uptake of the measles-mumps rubella (MMR) vaccine. Indeed, published 
estimates of influenza vaccination uptake based on aggregated extracts from primary care records 
show that 38% and 37% of pre-school children in England and Wales respectively were vaccinated in 
the 2014/15 season.[15,16] Vaccination uptake is also low (less than 10% in children overall) in some 
jurisdictions, such as Ontario (Canada) and Western Australia, where universal influenza vaccination 
of children has been recommended for several years.[17,18]  
Due to the requirement for annual vaccination, the recent change from a selective to universal 
programme, and the varying effectiveness between seasons, determinants of vaccination may differ 
between influenza and other childhood vaccines. An ecological study of pilot sites for the universal 
childhood programme in England in 2013/14 showed areas with higher deprivation, non-white or 
Muslim population to have lower uptake.[19] However, it is not certain whether these effects also 
operate at the individual level. Large general practice (GP) databases provide individual level 
information on important determinants of vaccination uptake including clinical risk factors, family 
structure and vaccination history. Here, we examine child and family risk factors associated with 
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influenza vaccination uptake in pre-school children in primary care in England and Wales, and 
examine variation in vaccination uptake by general practice. 
METHODS 
Data source 
We used The Health Improvement Network (THIN) for this study.[20] THIN is an electronic primary 
care database, covering approximately 6% of the UK population registered in a primary care practice 
who have agreed to submit data anonymously to THIN. THIN has been found to be representative of 
the UK population in terms of demographic characteristics and consultation patters.[21,22] THIN 
contains information on patient demographics, diagnoses, prescriptions, vaccinations and tests 
carried out in primary care; it does not cover procedures and diagnoses made in secondary care. 
Data are entered into patient electronic records by general practitioners (GPs, primary care 
clinicians) or nurses during patient consultations. Diagnoses are coded using Read codes [23] and 
prescriptions using drug codes which map onto the British National Formulary.[24]  
All THIN data are anonymised and originally collected for the purposes of clinical management. No 
ethnical review was sought based on advice from the NHS Health Research Authority.[25] The study 
was reviewed and approved by the Scientific Review Committee of the data providers, IMS Health 
(reference number SRC 14-004). 
Inclusion criteria 
We examined vaccination uptake in the 2014/15 season. This was the first season all pre-school 
children aged two years and older were offered vaccination in primary care. We extracted 
information from THIN on all children with complete data on the variables of interest, permanently 
registered with a GP practice contributing data to THIN in England or Wales, who were eligible to 
receive vaccination in primary care during the 2014/15 season. To be eligible, children had to be 
aged between two and four years inclusive on the 31st August 2014.[15] Vaccination status was 
determined on the 31st January 2015 to be able to compare uptake with published figures from 
England (the most populous country). In order to allow a sufficient time period to define risk factors 
for non-vaccination, children had to be registered with a THIN practice meeting quality criteria 
[26,27] since before their first birthday.  
Variable definitions 
Children who are not in risk groups (see below) are recommended to receive one dose of live 
attenuated influenza vaccine (LAIV), and children in risk groups are recommended to receive either 
one or two doses of LAIV or inactivated vaccine (IV) depending on their condition and vaccination 
history.[6] We determined for each child receipt of vaccination with LAIV or IV in the period between 
1st September 2014 and 31st January 2015. Children who had received at least one dose of LAIV or IV 
during the 2014/15 season were defined as vaccinated.  
Age (in single years) was calculated on the 31st August 2014 based on the child’s month and year of 
birth. Socio-economic status is available in THIN as quintile of the Townsend score, a small-area 
measure of deprivation derived at Census output area-level (approximately 150 households), based 
on the patient postcode.[28] The indicators used to derive the Townsend score (unemployment, 
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home and car ownership and overcrowding) came from the 2001 Census. We also determined the 
country of residence (England or Wales). An indicator of rurality was also available based on data 
from the 2001 Census and linked to the patient postcode.  
All patients in THIN are allocated a family number derived from the first line of the address of the 
patient, or other family members if registered in the same practice. We identified the number of 
other children (aged less than 18 years) in each family using the family number. We set the family 
number to missing if more than six children had the same family number, to avoid misclassification 
into families of some children living at addresses incorporating multiple households. We selected a 
random child from each family within the age group eligible to receive LAIV during 2014/15 season 
for inclusion in the cohort.  
We used pre-specified list of Read and drug codes to identify children in clinical risk groups,[29] used 
by the UK Department of Health to monitor vaccination uptake. It includes diagnostic codes for 
cystic fibrosis, bronchopulmonary dysplasia, congenital heart disease and cerebral palsy. Asthma 
was indicated by at least one prescription for oral steroids in a child with an asthma diagnosis code, 
at least one inhaled steroid prescription, or a diagnostic code indicating asthma-related hospital 
admission or medication. Children were classified as being in a clinical risk group if any of the 
relevant Read or drug codes were recorded in THIN between 31st January 2014 and 31st January 
2015.  
In the UK, children are recommended to receive their first dose of MMR vaccine at 12-13 months. 
We used timely receipt of MMR vaccine as an indicator of adherence with the childhood vaccination 
programme. Timely receipt of MMR vaccine was defined as at least one dose of MMR recorded 
between 12 and 18 months of age.  
Statistical analysis 
We estimated the proportion of children vaccinated against influenza (eg. received at least one dose 
of LAIV or IV) according to each exposure variable with 95% confidence intervals (CIs). Children in 
risk groups with no history of being immunised against influenza are recommended to receive two 
doses of vaccine. [6] We therefore determined the proportion of at-risk children not previously 
vaccinated against influenza prior to the 2014/15 season, who received two doses of vaccine 
according to recommendations. These children were defined as being vaccinated in the main 
analyses if they had received at least one dose of vaccine.  
We used mixed-effects Poisson regression models to model the association between each of the 
exposure variables of interest and the outcome (receipt of influenza vaccination) using Stata version 
13.[30]. Unadjusted and adjusted risk ratios (ARRs) were estimated using these models. We chose to 
fit a Poisson regression model to be able to estimate risk ratios rather than odds ratios since odds 
ratios will overestimate differences in risk when outcomes are common.[31] Poisson regression 
models can instead be used to obtain estimates of the risk ratio.[32] GP practice was included as a 
random effect to allow for practice-level variation in uptake. All exposure variables (age, Townsend 
quintile, number of other children in the family, presence of a chronic condition, timely receipt of 
MMR vaccination, sex, rurality and country) were considered for inclusion in the regression models, 
and were included in a forward stepwise procedure. Models were compared using the Akaike 
Information Criterion (AIC). If inclusion of an exposure variable reduced the AIC (compared to a 
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model excluding the variable) we considered this variable to significantly improve model fit, and the 
variable was included in the final multivariable model. As a sensitivity analysis, we also determined 
whether including the full THIN record (rather than one year prior to 31st January 2015) made a 
difference to the proportion of children in a risk group, vaccine uptake in risk groups, and the 
adjusted risk ratios by refitting the final model with this alternative method of identifying children in 
clinical risk groups.  
In order to examine practice-level variation in uptake over and above that explained by variation in 
the variables significantly associated with uptake in the final model, we calculated adjusted 
vaccination uptake rates for each practice. First, we refitted the final model as a logistic regression 
model (without a random effect) to be able to estimate the probability of receiving influenza 
vaccination for each child. We then summed these probabilities by GP practice to obtain the 
expected number of children vaccinated. We calculated adjusted vaccination uptake for practice j as 
𝑢𝑝𝑡𝑎𝑘𝑒_𝑎𝑑𝑗𝑗 = 𝑢𝑝𝑡𝑎𝑘𝑒_𝑡𝑜𝑡 ×
𝑜𝑏𝑠𝑗
𝑒𝑥𝑝𝑗
 
Where obsj and expj are the observed and expected number of children vaccinated in practice j 
respectively, and uptake_tot is the overall uptake of influenza vaccine in the child cohort. We used 
funnel plots with 95% limits calculated using normal approximation and adjusted for multiplicative 
overdispersion.[33] 
RESULTS 
The final sample included 57545 children, aged between 2 and 4 years on the 31st August 2014 who 
were registered with one of 290 general practices on 31st December 2015. Exclusions and the 
representativeness of the final sample are described in supplementary Figure S1 and supplementary 
Text S1.  
Overall, 22267 (38.7%, 95% CI 38.3%, 39.1%) of children had received at least one dose of influenza 
vaccine. The number and percentage of children who had received at least one dose of influenza 
vaccine according to the exposure variables are shown in Table 1. Only 3183 children (5.5%) were 
classified as being in a clinical risk group using the definition used to monitor vaccination uptake by 
the Department of Health. The most common risk condition was asthma: 3075 of 3183 children in a 
risk group had asthma (96.6%). 4428 children had received neither a timely first dose of MMR 
vaccine nor influenza vaccine (7.7%). 
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Table 1. The number of children vaccinated and the percentage of children who received at least 
one dose of influenza vaccine (vaccinated) according to sociodemographic and clinical 
characteristics, 2014/15 (n=57545) 
Variable Number of children 
(%) 
Number 
vaccinated 
% vaccinated (95% CI) 
Age (years) 
2 
3 
4 
 
20413 (35.5) 
19537 (34.0) 
17595 (30.6) 
 
8315 
8325 
5651 
 
40.7 (40.1, 41.4) 
42.6 (41.9, 43.3) 
32.1 (31.4, 32.8) 
In clinical risk group 
No 
Yes 
 
54362 (94.5) 
3183 (5.5) 
 
20604 
1687 
 
37.9 (37.5, 38.3) 
53.0 (51.2, 54.7) 
Number of other children in 
household 
0 
1 
2 
3 
4 
5 
 
 
17768 (30.9) 
25109 (43.6) 
9932 (17.3) 
3453 (6.0) 
994 (1.7) 
289 (0.5) 
 
 
7164 
10259 
3483 
1059 
258 
68 
 
 
40.3 (39.6, 41.0) 
40.9 (40.2, 41.5) 
35.1 (34.1, 36.0) 
30.7 (29.1, 32.2) 
26.0 (23.3, 28.8) 
23.5 (18.8, 28.9) 
Townsend quintile 
1st (Least deprived) 
2nd  
3rd 
4th 
5th (Most deprived) 
 
13110 (22.8) 
11474 (19.9) 
13026 (22.6) 
12178 (21.2) 
7757 (13.5) 
 
6113 
4803 
4882 
4124 
2369 
 
46.6 (45.8, 47.5) 
41.9 (41.0, 42.8) 
37.5 (36.6, 38.3) 
33.9 (33.0, 34.7) 
30.5 (29.5, 31.6) 
Timely first dose MMR 
vaccine  
No 
Yes 
 
 
5445 (9.5) 
52100 (90.5) 
 
 
1017 
21274 
 
 
18.7 (17.7, 19.7) 
40.8 (40.4, 41.3) 
Country 
England 
Wales 
 
49855 (86.6) 
7690 (13.4) 
 
19419 
2872 
 
39.0 (38.5, 39.4) 
37.3 (36.3, 38.4) 
Sex 
Male 
Female 
 
29531 (51.3) 
28014 (48.7) 
 
11520 
10771 
 
39.0 (38.5, 39.6) 
38.4 (37.9, 39.0) 
Rurality 
Urban 
Town/fringe 
Village/hamlet/isolated 
dwelling 
 
49862 (86.7) 
5138 (8.9) 
2545 (4.4) 
 
18823 
2333 
1135 
 
37.8 (37.3, 38.2) 
45.4 (44.0, 46.8) 
44.6 (42.7, 46.6) 
Total 57545 (100) 22291 38.7 (38.3, 39.1) 
Type of clinical risk group 
Asthma or chronic lung 
condition  
Chronic neurological 
condition 
Chronic heart condition 
Diabetes/chronic kidney/liver 
condition 
 
3079 (5.4) 
 
22 (0.04) 
 
35 (0.06) 
20 (0.03) 
 
 
1638 
 
12 
 
15 
12 
 
 
53.2 (51.4, 55.0) 
 
54.5 (32.2, 75.6) 
 
42.9 (26.3, 60.6) 
60.0 (36.1, 80.9) 
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Immunosuppression 
(including spleen conditions)  
28 (0.05) 
 
11 39.3 (21.5, 59.4) 
 
 
Of the 22291 children who had received vaccine, 21984 (98.6%) received one dose, and 307 children 
received two doses (1.4%); 92.7% of children who received one dose received LAIV (20383 children). 
Of the 307 children who received two doses, 255 children (83.1%) received two doses of LAIV, 40 
(13.0%) received two doses of IV; the remaining 12 (3.9%) children received one dose each of LAIV 
and IV. There were 1782 children in clinical risk groups who had no record of receiving influenza 
vaccine prior to the 2014/15 season. Of these children, 78 (4.4%) had received two doses of vaccine 
as recommended, 618 (34.7%) received one dose and 1086 (60.9%) were not vaccinated at all in the 
2014/15 season. 
Townsend quintile, age, number of other children in the household, timely receipt of MMR vaccine, 
and being in a clinical risk group were independently associated with receiving at least one dose of 
influenza vaccine in the final multi-level Poisson regression model (Table 2). The unadjusted and 
adjusted risk ratios were very similar, indicating that there was minimal confounding between the 
explanatory variables. The strongest association was seen for timely receipt of MMR vaccine; with 
children twice as likely to receive influenza vaccine if they also received timely MMR vaccine 
compared to children who did not (ARR: 2.00 (95% CI 1.87 to 2.13). Children living in the fifth most 
deprived areas were 19% less likely to receive influenza vaccine compared to children living in the 
least deprived areas (ARR 0.81, 95% CI 0.77, 0.86). Living with two or more other children also 
decreased the probability of being vaccinated: for example, children living with two other children 
were 10% less likely and those living with 5 other children (although rare) were 32% less likely to be 
vaccinated than children living with no other children (ARRs 0.90, 95% CI 0.86 to 0.94 and 0.68, 95% 
CI 0.53 to 0.86 respectively).  
Extending the time period used to determine whether a child was in a risk group increased the 
number of children in risk groups from 3183 to 5258 children (9.1% of all children), 2588 (48.5%) of 
whom were vaccinated. Inclusion of the revised risk group variable in the model reduced the ARR for 
risk group to 1.36 (95% CI 1.30, 1.41). The relative change in all other ARRs was less than 1%.  
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Table 2. Unadjusted risk ratios and adjusted risk ratios from mixed effects Poisson regression 
models (allowing for practice-level clustering) by the key risk factors (n=57545)* 
Variable Unadjusted risk ratio Adjusted risk ratio (ARR)** 
Age (years) 
2 
3 
4 
 
1  
1.04 (1.01, 1.08) 
0.78 (0.76, 0.81) 
 
1  
1.04 (1.01, 1.07) 
0.79 (0.76, 0.82) 
In clinical risk group 
No 
Yes 
 
1  
1.44 (1.37, 1.51) 
 
1  
1.45 (1.38, 1.53) 
Number of other children in 
household 
0 
1 
2 
3 
4 
5 
 
 
1  
0.98 (0.95, 1.01) 
0.86 (0.82, 0.89) 
0.77 (0.72, 0.82) 
0.67 (0.59, 0.76) 
0.60 (0.47, 0.76) 
 
 
1  
0.99 (0.96, 1.02) 
0.90 (0.86, 0.94) 
0.82 (0.77, 0.88) 
0.74 (0.65, 0.84) 
0.68 (0.53, 0.86) 
Townsend quintile 
1st (Least deprived) 
2nd  
3rd 
4th 
5th (Most deprived) 
 
1  
0.95 (0.91, 0.98) 
0.90 (0.86, 0.93) 
0.84 (0.81, 0.88) 
0.79 (0.75, 0.83) 
 
1  
0.95 (0.91, 0.98) 
0.90 (0.87, 0.94) 
0.86 (0.82, 0.89) 
0.81 (0.77, 0.86) 
Timely first dose MMR vaccine  
No 
Yes 
 
1  
2.08 (1.95, 2.22) 
 
1  
2.00 (1.87, 2.13) 
Country* 
England 
Wales 
 
1  
1.02 (0.88, 1.17) 
 
- 
Sex* 
Male 
Female 
 
1  
0.99 (0.96, 1.01) 
 
- 
Rurality* 
Urban 
Town/fringe 
Village/hamlet/isolated dwelling 
 
1  
1.05 (0.98, 1.13) 
1.02 (0.94, 1.10) 
 
- 
*Country, sex and rurality were not included in the final model.  
**Results from final model. ARRs are adjusted for all other variables in the model. AIC: 82820.8 
 
Practice-level vaccination uptake varied from 0% to 88.1%; the interdecile range was equal to 41.9% 
(17.4% to 59.3%). The substantial variation in uptake remained after adjustment for the risk factors 
included in the final model (Figure 1).  
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25 practices fell outside the 95% control limits of the funnel plot, whereas only 15 practices would 
be expected to fall outside the limits based on random variation alone.  
 
DISCUSSION 
In this large study of over 50,000 children, we found that less than 40% were vaccinated against 
influenza under the universal programme in England and Wales. Living in a deprived area, or in a 
family with two or more other children were significant risk factors for not being vaccinated against 
influenza. In contrast, being in a clinical risk group was associated with an increased likelihood of 
receiving the influenza vaccine. However, only half of children at increased risk of influenza 
complications due to chronic conditions were vaccinated, and less than 5% of children who were 
recommended to receive two doses of vaccine did so. We also identified substantial between-
practice variation in influenza vaccination uptake.  
Vaccination information in primary care is well recorded, since GPs are reimbursed by 
commissioners for vaccinating their patients, and the proportion of children in the cohort who were 
vaccinated against influenza was similar to published figures for vaccination uptake in England and 
Wales.[15,16] 
The main weakness of the study is that information on some risk factors for low vaccination uptake, 
including ethnicity[11] and maternal education[12] are either sparsely recorded or not available in 
primary care databases. Ethnic group in particular has been associated with childhood vaccination 
uptake in previous studies, and area-level ethnic composition and influenza vaccination uptake were 
associated in a pilot of the universal influenza vaccination programme in England.[19] The porcine 
component of LAIV makes ethnic group of particular interest for influenza vaccine.[34] Differences in 
ethnic group composition may partially explain some of the observed associations of deprivation and 
number of other children in the family with vaccination In addition, inclusion of ethnic group  as a 
variable in the regression models is likely to have improved model fit. Ethnic group recording is 
improving over time in UK primary care databases.[35] Future studies of influenza vaccine in children 
using these data could therefore assess the effect of ethnic group on uptake. 
THIN only covers vaccination given in primary care. Children vaccinated in other settings, including 
hospitals or pharmacies, would be misclassified as unvaccinated. There are no national data on 
influenza vaccinations provided in hospitals. Vaccination in hospital is only likely to be offered to 
children with chronic conditions managed in secondary rather than primary care- a very small 
proportion of children overall. Likewise, national data on influenza vaccinations in pharmacies are 
not available, but in the 2013/14 season at least, influenza vaccinations in community pharmacies 
were only widely accessed in some English localities.[36]  
We found an inverse association between area-level deprivation and influenza vaccination uptake. 
Studies of influenza vaccination uptake across all ages[37] and in risk groups[38] have shown similar 
results. The pilot study of the universal childhood influenza vaccination programme using 
deprivation determined at the GP practice level[19] showed a similar difference between the 
wealthiest and poorest deprivation quintile (12% cf. 16% here). Our finding of a negative association 
between the number of other children in the household and the likelihood of being vaccinated has 
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also been found for MMR vaccine.[12] Socio-economic deprivation has been associated with higher 
risk of influenza complications including hospital admission[1] and death.[39] Higher parity is 
associated with a higher risk of respiratory hospital admissions in children.[40] These findings 
indicate that efforts to increase vaccination uptake should be targeted to larger families and more 
deprived areas. 
We identified wide variation in uptake by GP practice even after adjusting for the individual-level risk 
factors. Some of this variation is likely to be explained by differences in the prevalence of risk factors 
that we could not measure and hence adjust for, for example ethnic group. Practice-level variation in 
access to vaccination for children, such as systems for inviting children to be vaccinated and opening 
hours, may also contribute to the observed variation. There is not a national target for influenza 
vaccine uptake in children, although NHS England states that an uptake rate of 40% should be 
achievable in the 2015/16 season, and all children should be invited to be vaccinated.[41] A recent 
systematic review showed that reminder letters appeared to increase uptake in children in risk 
groups in the US. However, there is little research into other strategies, particularly in a non-US 
setting.[42] Interventions for improving uptake of influenza vaccine in children, particularly in risk 
groups, should therefore be seen as a research priority. The effect of improving access to vaccination 
through pharmacies, nurseries or local children’s centres in deprived areas, or in secondary care for 
children with chronic conditions should be assessed. Integration of national data collection streams 
including primary care and child health records is required to measure the impact of such 
interventions. 
Uptake in the national influenza vaccination programme is therefore substantially lower than for 
other routine childhood vaccinations in the UK. This could be due to several factors. Influenza is a 
new vaccine in the UK, and the uncertainties about effectiveness and safety may discourage parents. 
However rotavirus vaccine was introduced in June 2013, and 88% uptake was achieved for two 
doses by March 2015 in England.[43] However, unlike the rotavirus vaccine which is given at the 
same time as other routine infant vaccines, influenza vaccination in pre-school children requires a 
special appointment with the GP. Qualitative studies show that apart from difficulties in accessing 
vaccination clinics, parental perceptions of influenza as a less severe illness and worries about side 
effects all play a part in parents’ decision to vaccinate,[44] and such factors may contribute to low 
vaccination uptake. This has been compounded by uncertainties about influenza vaccine 
effectiveness, particularly during the 2013/14 when there was a poor match between circulating and 
vaccine strains,[45] which was widely reported by the media. Further studies are required to 
examine whether influenza vaccine can reduce the risk of hospital admissions and deaths in children 
and to quantify the risk of adverse events, particularly among children in risk groups. 
The influenza vaccination programme in preschool children has the lowest uptake of any of the 
vaccines offered through the universal childhood immunisation programme in the UK. This may be 
due to parental perceptions of influenza as a low-risk illness or a lack of access to vaccination 
services. Strategies to increase uptake should be targeted to children at increased risk of influenza 
complications, such as children in risk groups, deprived areas or larger families.  
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FIGURE LEGENDS 
Figure 1. Funnel plot of adjusted vaccination uptake rates with 95% overdispersion adjusted control 
limits 
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Supplementary Text S1: Exclusions and representativeness of the final study sample 
Some children aged 2-4 years on the 31st August 2014 and registered in a THIN practice on the 31st 
January 2015 were not included in the final study sample due to missing data or because they were 
not registered with a THIN practice meeting quality criteria since before their first birthday. Also, onl 
one child per family was included – one child per family was therefore randomly selected. 
Figure S1 outlines the number of children excluded at each stage. 
Children not excluded at random (n=31,240) were similar in terms of gender (48.5% of children 
excluded were girls compared to 48.8% of children in the study (χ2 p =0.39). Excluded children were 
significantly older, although the absolute difference was small; the mean age of children in the study 
was 3.0 years compared to 3.1 years among children who were excluded t-test p<0.001. Excluded 
children were less likely to be vaccinated, yet the absolute difference was small: 39% in the cohort 
cf. 34% among children who were excluded. The slightly lower uptake among children who were 
excluded is partly due to excluding children who were registered in a THIN practice during the 
autumn of 2014. Hence they may have been vaccinated in another GP practice, but this is not 
captured in THIN.  
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Figure S1.  
 
 
